Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS reform

- PMLiVE

Controversial new CDF promises “clearer, faster decision-making”

However, pharma companies and charities remain concerned over pricing and access

Bristol-Myers Squibb (BMS) building

NICE finalises record-breaking Opdivo/Yervoy appraisal

BMS’s immunotherapy combination receives recommendation in 24 days

EISAI

Eisai slams Cancer Drugs Fund ‘black hole’

Will consider legal action to address the ‘unfair and inequitable situation’ for UK cancer patients

ABPI London offices

UK pharma HCP payment database goes live

Two-thirds of payments related to research and development work

- PMLiVE

Connected Healthcare

Digital technologies are bringing healthcare professionals (HCPs) and their patients ever closer, and the potential benefits of this type of engagement seem to be many.

Celgene building

NICE rejects Celgene’s Vidaza for leukaemia

Final draft guidance cites ‘high degree of uncertainty’ over clinical efficacy

- PMLiVE

Achieving the NHS’s vision through service redesign and pathway efficiencies

Technology and data sharing are at the heart of new NHS vanguard

- PMLiVE

A rare opportunity

Sobi’s Neil Dugdale on how the UK’s approach to rare diseases is changing

National Institute for Health and Care Excellence NICE logo

NICE gives green light to Sanofi’s Jevtana for prostate cancer

Undisclosed discount for NHS encourages U-turn to back the chemotherapy drug

- PMLiVE

Healthcare costs

The technology poised to drive down the cost of healthcare

- PMLiVE

Med comms has a ‘big role to play’ in market access

HCA meeting hears communications can assist companies with the process

- PMLiVE

Norman Lamb: Health savings ‘unachievable’ under current approach

Former minister says health system's ‘existential challenge’ needs new thinking

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links